NDC 53808-1069

nevirapine

Nevirapine

nevirapine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by State Of Florida Doh Central Pharmacy. The primary component is Nevirapine.

Product ID53808-1069_61573dec-d862-4d5d-a2b9-59c2f1ded71f
NDC53808-1069
Product TypeHuman Prescription Drug
Proprietary Namenevirapine
Generic NameNevirapine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2014-11-01
Marketing CategoryANDA / ANDA
Application NumberANDA203176
Labeler NameState of Florida DOH Central Pharmacy
Substance NameNEVIRAPINE
Active Ingredient Strength200 mg/1
Pharm ClassesHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 53808-1069-1

30 TABLET in 1 BLISTER PACK (53808-1069-1)
Marketing Start Date2014-11-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 53808-1069-1 [53808106901]

nevirapine TABLET
Marketing CategoryANDA
Application NumberANDA203176
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-11-01
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
NEVIRAPINE200 mg/1

OpenFDA Data

SPL SET ID:ea81309d-c41e-404a-8ad2-f232c4587a87
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 199422

    • Pharmacological Class

    • Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Non-Nucleoside Analog [EXT]
    • Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Cytochrome P450 3A Inducers [MoA]
    • Cytochrome P450 2B6 Inducers [MoA]

    NDC Crossover Matching brand name "nevirapine" or generic name "Nevirapine"

    NDCBrand NameGeneric Name
    0378-4050Nevirapinenevirapine
    0378-4890Nevirapinenevirapine
    0378-6950Nevirapinenevirapine
    0781-5893NevirapineNevirapine
    31722-505NevirapineNevirapine
    33342-004NevirapineNevirapine
    33342-238NEVIRAPINENEVIRAPINE
    42571-131NEVIRAPINENEVIRAPINE
    51991-331NevirapineNEVIRAPINE
    53104-0166nevirapinenevirapine
    53808-0680Nevirapinenevirapine
    53808-1069nevirapinenevirapine
    61442-470NevirapineNevirapine
    64380-709NevirapineNevirapine
    65162-209NevirapineNevirapine
    69097-403NEVIRAPINENEVIRAPINE
    69097-233nevirapinenevirapine
    65862-057NevirapineNevirapine
    65862-027NevirapineNevirapine
    65862-932NEVIRAPINENEVIRAPINE
    65862-933NEVIRAPINENEVIRAPINE
    47781-317Nevirapine Extended Releasenevirapine
    0597-0046Viramunenevirapine
    0597-0047Viramunenevirapine
    0597-0123Viramunenevirapine
    53808-0808Viramunenevirapine
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.